Cargando…

Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada

Objectives: To explore community pharmacies’ experience with two models of distribution for publicly-funded influenza vaccines in Ontario, Canada—one being publicly-managed (2015–2016 influenza season) and one involving private pharmaceutical distributors (2016–2017 season). Methods: Online surveys...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Joseph, Violette, Richard, Houle, Sherilyn K. D., Waite, Nancy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167743/
https://www.ncbi.nlm.nih.gov/pubmed/33923195
http://dx.doi.org/10.3390/pharmacy9020094
_version_ 1783701752660361216
author Fonseca, Joseph
Violette, Richard
Houle, Sherilyn K. D.
Waite, Nancy M.
author_facet Fonseca, Joseph
Violette, Richard
Houle, Sherilyn K. D.
Waite, Nancy M.
author_sort Fonseca, Joseph
collection PubMed
description Objectives: To explore community pharmacies’ experience with two models of distribution for publicly-funded influenza vaccines in Ontario, Canada—one being publicly-managed (2015–2016 influenza season) and one involving private pharmaceutical distributors (2016–2017 season). Methods: Online surveys were distributed to community pharmacies across Ontario during the 2015–2016 and 2016–2017 influenza seasons with sampling proportional to Ontario Public Health Unit catchment populations. Quantitative data were analyzed descriptively and inferentially and qualitative data were summarized for additional context. Results: Order fulfillment appeared more responsive with the addition of private distributors in 2016–2017, as more pharmacies reported shorter order fulfillment times (p < 0.01); however, pharmacies reported significantly more days with zero on-hand inventory in 2016–2017 (p < 0.01), as well as more instances of patients being turned away due to vaccine unavailability (p < 0.05). In both seasons, a similar proportion of pharmacies reported slower order fulfillment and limited order quantities early in the season. Improved availability early in the season when patient demand is highest, more vaccines in a pre-filled syringe format, and better communication from distributors on product availability dates were recommended in qualitative responses. Conclusions: Introducing private distributors for the management and fulfillment of pharmacies’ orders for the publicly funded influenza vaccine appeared to have mixed results. While key concerns surrounding the frequency, responsiveness, and method of delivery were addressed by this change, challenges remain—in particular, acquiring sufficient vaccine early in the season to meet patient demand. As pharmacies become more prominent as vaccination sites, there are several opportunities to ensure that patient demand is met in this setting.
format Online
Article
Text
id pubmed-8167743
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81677432021-06-02 Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada Fonseca, Joseph Violette, Richard Houle, Sherilyn K. D. Waite, Nancy M. Pharmacy (Basel) Article Objectives: To explore community pharmacies’ experience with two models of distribution for publicly-funded influenza vaccines in Ontario, Canada—one being publicly-managed (2015–2016 influenza season) and one involving private pharmaceutical distributors (2016–2017 season). Methods: Online surveys were distributed to community pharmacies across Ontario during the 2015–2016 and 2016–2017 influenza seasons with sampling proportional to Ontario Public Health Unit catchment populations. Quantitative data were analyzed descriptively and inferentially and qualitative data were summarized for additional context. Results: Order fulfillment appeared more responsive with the addition of private distributors in 2016–2017, as more pharmacies reported shorter order fulfillment times (p < 0.01); however, pharmacies reported significantly more days with zero on-hand inventory in 2016–2017 (p < 0.01), as well as more instances of patients being turned away due to vaccine unavailability (p < 0.05). In both seasons, a similar proportion of pharmacies reported slower order fulfillment and limited order quantities early in the season. Improved availability early in the season when patient demand is highest, more vaccines in a pre-filled syringe format, and better communication from distributors on product availability dates were recommended in qualitative responses. Conclusions: Introducing private distributors for the management and fulfillment of pharmacies’ orders for the publicly funded influenza vaccine appeared to have mixed results. While key concerns surrounding the frequency, responsiveness, and method of delivery were addressed by this change, challenges remain—in particular, acquiring sufficient vaccine early in the season to meet patient demand. As pharmacies become more prominent as vaccination sites, there are several opportunities to ensure that patient demand is met in this setting. MDPI 2021-04-24 /pmc/articles/PMC8167743/ /pubmed/33923195 http://dx.doi.org/10.3390/pharmacy9020094 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fonseca, Joseph
Violette, Richard
Houle, Sherilyn K. D.
Waite, Nancy M.
Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada
title Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada
title_full Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada
title_fullStr Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada
title_full_unstemmed Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada
title_short Distributing Publicly-Funded Influenza Vaccine—Community Pharmacies’ Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada
title_sort distributing publicly-funded influenza vaccine—community pharmacies’ perspectives on acquiring vaccines from public health and from private distributors in ontario, canada
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167743/
https://www.ncbi.nlm.nih.gov/pubmed/33923195
http://dx.doi.org/10.3390/pharmacy9020094
work_keys_str_mv AT fonsecajoseph distributingpubliclyfundedinfluenzavaccinecommunitypharmaciesperspectivesonacquiringvaccinesfrompublichealthandfromprivatedistributorsinontariocanada
AT violetterichard distributingpubliclyfundedinfluenzavaccinecommunitypharmaciesperspectivesonacquiringvaccinesfrompublichealthandfromprivatedistributorsinontariocanada
AT houlesherilynkd distributingpubliclyfundedinfluenzavaccinecommunitypharmaciesperspectivesonacquiringvaccinesfrompublichealthandfromprivatedistributorsinontariocanada
AT waitenancym distributingpubliclyfundedinfluenzavaccinecommunitypharmaciesperspectivesonacquiringvaccinesfrompublichealthandfromprivatedistributorsinontariocanada